Toll-like receptors: new therapeutic targets for autoimmune diseases

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.23, Iss.6, 2002-06, pp. : 257-257

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Toll-like receptors as therapeutic targets in gastrointestinal diseases

By Pimentel-Nunes Pedro Soares João Bruno Roncon-Albuquerque Jr Roberto Dinis-Ribeiro Mário Leite-Moreira Adelino F

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 4, 2010-04 ,pp. : 347-368

Informa Healthcare

Access to resources Recommend Favorite

The TOLL-like / Type-I Interferon Pathways as Emerging Therapeutic Targets for Autoimmune Diseases

Drug Design Reviews - Online, Vol. 1, Iss. 1, 2004-01 ,pp. : 53-74

Bentham Science Publishers

Access to resources Recommend Favorite

Toll-like receptors as potential therapeutic targets in cardiac dysfunction

By Hofmann Ulrich Ertl Georg Frantz Stefan

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 6, 2011-06 ,pp. : 753-765

Informa Healthcare

Access to resources Recommend Favorite

Editorial [Hot Topic: Toll-Like Receptors and Innate Immunity: Potential Drug Targets for Treatment of Infectious, Inflammatory, and Autoimmune Diseases (Executive Editor: Emilio Jirillo)]

Current Pharmaceutical Design, Vol. 12, Iss. 32, 2006-11 ,pp. : 4089-4090

Bentham Science Publishers

Access to resources Recommend Favorite

Toll-Like Receptors and Kidney Diseases

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 8, Iss. 3, 2009-07 ,pp. : 191-201

Bentham Science Publishers

Access to resources Recommend Favorite